Ruthenium complex binding to DNA G-quadruplexes
与 DNA G 四链体结合的钌络合物
基本信息
- 批准号:BB/T008342/1
- 负责人:
- 金额:$ 67.38万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2020
- 资助国家:英国
- 起止时间:2020 至 无数据
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
In 2013 it was shown for the first time that the DNA 'knot' known as the G-quadruplex was present in human cells. A single strand of DNA containing four runs of guanine bases with the sequence -GGG- in each, for example, can fold up in the presence of potassium ions to give a rather stable structure. For many years, this was a lab curiosity, of interest to nucleic acid enthusiasts but of little practical benefit. This situation changed strikingly once the structures were shown to be part of the intrinsic mechanism of the living cell. The best known structure is that found at the ends of chromosomes, which mainly consist of large amounts of double helical DNA. At one end, there is what looks like a frayed end, a single strand consisting of hundreds of repeats of the DNA sequence -GGGTTA-. In normal ageing these frayed ends become shorter and shorter as the cell repeatedly divides, leading to eventual cell death. More recently, though, it has been estimated that the human genome contains maybe 300,000 regions where a G-quadruplex could form. Importantly, some of these are now thought to be associated with the switching on and off of genes. Cancer and other diseases of the genes are associated with the inappropriate switching of genes, often as a result of genetic damage. Therefore there is great interest in small molecules which can interact specifically with these knots, to recognise them, to trap them, and to visualise them for example. Hundreds of such molecules are known, with varying degrees of specificity and binding strength.In Reading we have carried out 3D structural work on the binding to DNA of a group of ruthenium compounds related to the so-called 'light-switch' compound, which takes its nickname from is luminescence (glow-in-the-dark) property when bound to DNA but not in water. There is a large family of compounds with related properties, some causing DNA damage on irradiation and therefore of interest for possible tumour therapy. Our work has shown the structural origin of the luminescence and the DNA damage.In this work we will develop compounds showing specific recognition properties for G-quadruplexes. These compounds will not bind at all to normal double helical DNA but would just recognise the 'knot', and ideally, specific 'knots'. We have unpublished results which give us some strong pointers, including a crystal structure showing one of our new ruthenium complexes bound to a G-quadruplex. Our Japanese collaborators have other preliminary results strongly suggestive of specificity as well, using another of our new complexes. First, the copying process of normal DNA in living systems requires, among other things, the disentangling of these 'knots'. One of our compounds greatly hinders this knot-untying process, suggesting a strong and specific binding. Second, it is now possible to buy an antibody which binds specifically to the 'knots' in whole cells, but again, the binding mode of the antibody is not yet clear. This is a different way to study how the 'knots' are involved in cell regulation, and can be used to study healthy vs cancerous cells. This compound displaces the antibody, again suggesting strong and specific binding.
2013年,科学家首次发现人类细胞中存在被称为G-quadruplex的DNA“结”。例如,一条含有四个鸟嘌呤碱基的单链DNA,每个碱基的序列都是GGG,在钾离子存在的情况下,它可以折叠起来,形成一个相当稳定的结构。多年来,这是一个实验室的好奇心,核酸爱好者感兴趣,但几乎没有实际好处。一旦这些结构被证明是活细胞内在机制的一部分,这种情况就发生了惊人的变化。最著名的结构是在染色体末端发现的,主要由大量的双螺旋DNA组成。在一端,有一个看起来像磨损的末端,一个由数百个重复的DNA序列组成的单链-GGGTTA-。在正常的衰老过程中,随着细胞不断分裂,这些磨损的末端变得越来越短,最终导致细胞死亡。然而,最近有人估计,人类基因组可能包含30万个G-四链体可以形成的区域。重要的是,其中一些现在被认为与基因的开启和关闭有关。癌症和其他基因疾病与基因的不适当转换有关,通常是遗传损伤的结果。因此,人们对能够与这些结特异性相互作用的小分子产生了极大的兴趣,例如识别它们,捕获它们,并使它们可视化。已知有数百种此类分子,具有不同程度的特异性和结合强度。在阅读中,我们对一组钌化合物与DNA的结合进行了3D结构工作,这些化合物与所谓的“光开关”化合物相关,其绰号来自于与DNA结合时的发光(在黑暗中发光)性质,但在水中则不然。有一个大家族的化合物具有相关的性质,一些导致DNA损伤的辐射,因此可能的肿瘤治疗的兴趣。我们的工作揭示了发光和DNA损伤的结构来源,在这项工作中,我们将开发出对G-四链体具有特异识别性能的化合物。这些化合物根本不会与正常的双螺旋DNA结合,而只是识别“结”,理想情况下,是特异性的“结”。我们有一些未发表的结果,这些结果给了我们一些强有力的指示,包括显示我们的一种新的钌配合物与G-四链体结合的晶体结构。我们的日本合作者使用我们的另一种新复合物,也得到了其他强烈暗示特异性的初步结果。首先,生命系统中正常DNA的复制过程需要解开这些“结”。我们的一种化合物极大地阻碍了这种结的解开过程,这表明了一种强而特异的结合。其次,现在可以买到一种抗体,它可以特异性地结合整个细胞中的“结”,但同样,抗体的结合模式还不清楚。这是研究“结”如何参与细胞调节的另一种方法,可用于研究健康细胞与癌细胞。该化合物取代抗体,再次表明强和特异性结合。
项目成果
期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Understanding the factors controlling the photo-oxidation of natural DNA by enantiomerically pure intercalating ruthenium polypyridyl complexes through TA/TRIR studies with polydeoxynucleotides and mixed sequence oligodeoxynucleotides.
- DOI:10.1039/d0sc02413a
- 发表时间:2020-08-06
- 期刊:
- 影响因子:8.4
- 作者:Keane PM;O'Sullivan K;Poynton FE;Poulsen BC;Sazanovich IV;Towrie M;Cardin CJ;Sun XZ;George MW;Gunnlaugsson T;Quinn SJ;Kelly JM
- 通讯作者:Kelly JM
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Christine Janet Cardin其他文献
Christine Janet Cardin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Christine Janet Cardin', 18)}}的其他基金
ETNA - Expansion of the Time domain in Nucleic Acid crystallography
ETNA - 核酸晶体学中时域的扩展
- 批准号:
BB/M004635/1 - 财政年份:2014
- 资助金额:
$ 67.38万 - 项目类别:
Research Grant
Metal polypyridyl complex interactions with duplex and higher order DNAs
金属聚吡啶复合物与双链体和高阶 DNA 的相互作用
- 批准号:
BB/K019279/1 - 财政年份:2013
- 资助金额:
$ 67.38万 - 项目类别:
Research Grant
相似国自然基金
TPLATE Complex通过胞吞调控CLV3-CLAVATA多肽信号模块维持干细胞稳态的分子机制研究
- 批准号:32370337
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
二甲双胍对于模型蛋白、γ-secretase、Complex I自由能曲面的影响
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
高脂饮食损伤巨噬细胞ndufs4表达激活Complex I/mROS/HIF-1通路参与溃疡性结肠炎研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
利用新型 pH 荧光探针研究 Syntaxin 12/13 介导的多种细胞器互作
- 批准号:92054103
- 批准年份:2020
- 资助金额:87.0 万元
- 项目类别:重大研究计划
S-棕榈酰化新型修饰在细胞自噬中的功能和机制研究
- 批准号:31970693
- 批准年份:2019
- 资助金额:58.0 万元
- 项目类别:面上项目
核孔复合体调控细胞核/叶绿体信号交流分子机制的研究
- 批准号:31970656
- 批准年份:2019
- 资助金额:52.0 万元
- 项目类别:面上项目
m6A甲基化酶ZCCHC4结合EIF3复合物调节翻译的机制研究
- 批准号:31971330
- 批准年份:2019
- 资助金额:62.0 万元
- 项目类别:面上项目
线粒体参与呼吸中枢pre-Bötzinger complex呼吸可塑性调控的机制研究
- 批准号:31971055
- 批准年份:2019
- 资助金额:58.0 万元
- 项目类别:面上项目
北温带中华蹄盖蕨复合体Athyrium sinense complex的物种分化
- 批准号:31872651
- 批准年份:2018
- 资助金额:60.0 万元
- 项目类别:面上项目
细胞不对称分裂时PAR-3/PAR-6复合物极性聚集的分子机制研究
- 批准号:31871394
- 批准年份:2018
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
Impact of Solute Carriers on Ruthenium Complex Sensitivity in Yeast
溶质载体对酵母中钌络合物敏感性的影响
- 批准号:
10360056 - 财政年份:2022
- 资助金额:
$ 67.38万 - 项目类别:
Ruthenium complex binding to DNA G-quadruplexes
与 DNA G 四链体结合的钌络合物
- 批准号:
BB/T007893/1 - 财政年份:2020
- 资助金额:
$ 67.38万 - 项目类别:
Research Grant
Optimizing Protic Ruthenium Anticancer Compounds for Singlet Oxygen Production and Enhanced Photocytotoxicity
优化质子钌抗癌化合物以产生单线态氧并增强光细胞毒性
- 批准号:
10579670 - 财政年份:2019
- 资助金额:
$ 67.38万 - 项目类别:
RU K-EDGE EXAFS ANALYSIS OF A RUTHENIUM ANTICANCER DRUG-TRANSFERRIN ADDUCT
钌抗癌药物-转铁蛋白加合物的 RU K-EDGE EXAFS 分析
- 批准号:
8362258 - 财政年份:2011
- 资助金额:
$ 67.38万 - 项目类别:
K-EDGE EXAFS ANALYSIS OF A RUTHENIUM ANTICANCER DRUG-TRANSFERRIN ADDUCT
钌抗癌药物-转铁蛋白加合物的 K 边 EXAFS 分析
- 批准号:
8362379 - 财政年份:2011
- 资助金额:
$ 67.38万 - 项目类别:
ANTICAN THIOSEMICARBAZONE COMPXS OF RUTHENIUM&COPPER/SYNTHESIS BIOCHEM&CELLULAR
钌抗硫缩氨基脲络合物
- 批准号:
8168100 - 财政年份:2010
- 资助金额:
$ 67.38万 - 项目类别:
ANTICAN THIOSEMICARBAZONE COMPXS OF RUTHENIUM&COPPER/SYNTHESIS BIOCHEM&CELLULAR
钌抗硫缩氨基脲络合物
- 批准号:
7959439 - 财政年份:2009
- 资助金额:
$ 67.38万 - 项目类别:
ANTICAN THIOSEMICARBAZONE COMPXS OF RUTHENIUM&COPPER/SYNTHESIS BIOCHEM&CELLULAR
钌抗硫缩氨基脲络合物
- 批准号:
7725077 - 财政年份:2008
- 资助金额:
$ 67.38万 - 项目类别:
Redox-Active Ruthenium Complexes for Cancer Treatment
用于癌症治疗的氧化还原活性钌配合物
- 批准号:
7778988 - 财政年份:2006
- 资助金额:
$ 67.38万 - 项目类别:
HEME PROTEIN MODEL STUDIES UTILIZING RUTHENIUM PORPHYRINS
利用钌卟啉进行血红素蛋白模型研究
- 批准号:
3734256 - 财政年份:
- 资助金额:
$ 67.38万 - 项目类别: